{"gene":"TSC22D2","run_date":"2026-04-28T21:43:00","timeline":{"discoveries":[{"year":2006,"finding":"TSC22D2 transcripts are transiently upregulated by hyperosmolality in mouse kidney cells (mIMCD3) via mRNA stabilization, and overexpression of TSC22D2-4 confers protection against osmotic stress, increasing cell survival 2.7-fold at high osmolality.","method":"mRNA stability assays, overexpression in mIMCD3 cells with osmotic stress survival assay","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 — clean overexpression with defined phenotypic readout and mechanistic basis (mRNA stabilization), single lab","pmids":["17147695"],"is_preprint":false},{"year":2012,"finding":"TSC22D2 protein accumulates upon loss of NRBP1 in the intestine, placing TSC22D2 downstream of NRBP1-mediated ubiquitination machinery in intestinal progenitor cell fate regulation.","method":"Genetic loss-of-function (Nrbp1 somatic deletion in mouse intestine), immunoblotting for Tsc22d2 accumulation, interaction studies with ubiquitination machinery","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with defined cellular phenotype and pathway placement, single lab","pmids":["22510880"],"is_preprint":false},{"year":2016,"finding":"TSC22D2 directly interacts with pyruvate kinase isoform M2 (PKM2); overexpression of TSC22D2 reduces nuclear PKM2 levels and suppresses cyclin D1 expression, inhibiting colorectal cancer cell growth.","method":"Co-immunoprecipitation combined with mass spectrometry, immunoprecipitation, immunofluorescence, overexpression assays","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 3 — co-IP/MS with functional follow-up, single lab, moderate orthogonal evidence","pmids":["27573352"],"is_preprint":false},{"year":2016,"finding":"TSC22D2 interacts with WDR77 (a protein involved in cell cycle and tumor development), as validated by immunoprecipitation and immunofluorescence; yeast two-hybrid screening identified 44 potential TSC22D2-interacting partners involved in transcription, metabolism, and cell cycle regulation.","method":"Yeast two-hybrid screening, immunoprecipitation, immunofluorescence","journal":"Tumour biology","confidence":"Low","confidence_rationale":"Tier 3 — single Co-IP/pulldown with limited functional follow-up, single lab","pmids":["27337956"],"is_preprint":false},{"year":2019,"finding":"The histone H4 transcription factor HINFP binds to the promoter region of TSC22D2 and may regulate its transcription.","method":"Promoter binding assay (HINFP binding to TSC22D2 promoter region), whole-exome sequencing and linkage analysis","journal":"Carcinogenesis","confidence":"Low","confidence_rationale":"Tier 3 — single binding assay without functional mutagenesis validation, single lab","pmids":["31125406"],"is_preprint":false},{"year":2023,"finding":"TSC22D2 participates in STAT3 signaling and AMPKα-mTOR pathway: anti-inflammatory miRNAs in macrophage-derived extracellular vesicles decrease TSC22D2 expression, which upregulates Treg differentiation via TSC22D2-STAT3 signaling and inhibits M1 macrophage polarization via TSC22D2-AMPKα-mTOR pathway.","method":"miRNA delivery via extracellular vesicles, knockdown/pathway inhibition experiments in macrophages, in vivo mouse model of sepsis-associated acute liver injury","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 — KD with defined pathway readouts (STAT3, AMPKα-mTOR) and in vivo validation, single lab","pmids":["37554446"],"is_preprint":false},{"year":2024,"finding":"TSC22D2 interacts with ACOT8 (acyl-coenzyme A thioesterase 8) and maintains ACOT8 stability; overexpression of TSC22D2 promotes ACOT8 expression and inhibits colorectal cancer cell proliferation and metastasis through an EMT mechanism.","method":"Co-immunoprecipitation combined with mass spectrometry, Western blot, immunoprecipitation, in vitro and in vivo (subcutaneous mouse model) functional assays","journal":"OncoTargets and therapy","confidence":"Medium","confidence_rationale":"Tier 3 — co-IP/MS with in vivo functional validation, single lab","pmids":["38476309"],"is_preprint":false},{"year":2024,"finding":"Within seconds of hyperosmotic stress, TSC22D2 physically associates with WNK1 and NRBP1 into biomolecular condensates in a process dependent on intrinsically disordered regions (IDRs). TSC22D family genes co-evolved with a specific NRBP-binding domain (NbrT) in NRBPs and with IDR expansion in WNK kinases across metazoans to co-regulate rapid cell volume changes.","method":"Gene co-essentiality analysis, live-cell imaging of condensate formation, CRISPR-based endogenous protein tagging, proximity labeling, immunoprecipitation, evolutionary/domain analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (co-essentiality, imaging, proximity labeling, IP, evolutionary analysis), strong evidence for condensate formation mechanism","pmids":["38980795"],"is_preprint":false},{"year":2025,"finding":"TSC22D2 physically associates with WNK1 and NRBP1 upon osmotic stress (confirmed by immunoprecipitation, mass spectrometry, and proximity labeling). NRBP1 directly activates WNK4 in vitro, and AlphaFold-3 modeling predicts TSC22D4 RΦ-motifs interact with the CCT domain of NRBP1 in a complex also containing WNK1 and SPAK; TSC22D proteins serve as adaptors bridging NRBP1 and WNK kinases in the osmosensing pathway.","method":"Proximity labeling, immunoprecipitation, mass spectrometry, immunoblotting, in vitro kinase assay (recombinant NRBP1 activating WNK4), AlphaFold-3 structural modeling, NRBP1 knockdown/knockout","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution of WNK4 activation, structural modeling, reciprocal IP/MS, KO functional validation, multiple orthogonal methods in single study","pmids":["40668933"],"is_preprint":false},{"year":2025,"finding":"TSC22D2 localizes to cytoplasmic biomolecular condensates (WNK bodies) in the distal convoluted tubule (DCT) of the kidney, and long TSC22D isoforms including TSC22D2 positively modulate WNK4 activity in HEK293 cells, thereby regulating NCC phosphorylation and Na+ reabsorption in the kidney.","method":"Immunofluorescence localization in DCT, HEK293 cell overexpression with WNK4 activity assay, DCT-specific NRBP1 knockout mice with NCC phosphorylation readout","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 — direct localization with functional consequence, in vitro kinase assay, in vivo KO mouse, multiple orthogonal methods","pmids":["40668923"],"is_preprint":false}],"current_model":"TSC22D2 is an adaptor protein that, upon hyperosmotic stress, rapidly associates with WNK1 kinase and the NRBP1 pseudokinase into biomolecular condensates via intrinsically disordered regions, where it positively modulates WNK kinase activity to regulate cell volume homeostasis, ion transport (NCC phosphorylation), and Na+ reabsorption in the kidney; additionally, TSC22D2 interacts with PKM2 and ACOT8 to suppress cancer cell growth, and its expression is regulated by HINFP at the promoter level and post-transcriptionally by mRNA stabilization during osmotic stress."},"narrative":{"teleology":[{"year":2006,"claim":"TSC22D2 was first linked to osmotic stress responses when its mRNA was found to be stabilized under hyperosmolality, and overexpression conferred cytoprotection — establishing TSC22D2 as an osmotically responsive gene with a pro-survival role.","evidence":"mRNA stability assays and overexpression survival assays in mIMCD3 kidney cells","pmids":["17147695"],"confidence":"Medium","gaps":["Downstream mechanism of cytoprotection unknown","No interacting partners identified","Single cell line tested"]},{"year":2012,"claim":"The discovery that TSC22D2 protein accumulates upon NRBP1 loss in mouse intestine established that TSC22D2 is a regulated substrate of NRBP1-dependent ubiquitination, revealing post-translational control of TSC22D2 levels.","evidence":"Somatic deletion of Nrbp1 in mouse intestine with immunoblotting for Tsc22d2","pmids":["22510880"],"confidence":"Medium","gaps":["Whether NRBP1-TSC22D2 interaction is direct or mediated by an E3 ligase was unclear","Functional consequence of TSC22D2 accumulation in intestinal cells not defined"]},{"year":2016,"claim":"Identification of PKM2 as a direct TSC22D2 interactor, with TSC22D2 reducing nuclear PKM2 and cyclin D1, provided the first evidence for a tumor-suppressive mechanism involving sequestration of an oncogenic metabolic enzyme.","evidence":"Co-IP/MS, immunofluorescence, and overexpression in colorectal cancer cells","pmids":["27573352"],"confidence":"Medium","gaps":["No loss-of-function validation of the PKM2-sequestration model","Mechanism of PKM2 nuclear exclusion not defined","In vivo tumor suppression not tested"]},{"year":2023,"claim":"TSC22D2 was placed in immune signaling when knockdown showed it modulates Treg differentiation via STAT3 and M1 macrophage polarization via AMPKα-mTOR, broadening its known functions beyond osmotic stress and cancer.","evidence":"miRNA-mediated knockdown in macrophages with pathway inhibition, in vivo sepsis mouse model","pmids":["37554446"],"confidence":"Medium","gaps":["Whether TSC22D2 acts as a direct signaling node or a transcriptional target in these pathways is unclear","Single disease model (sepsis-associated liver injury)"]},{"year":2024,"claim":"A second tumor-suppressive mechanism was identified: TSC22D2 stabilizes ACOT8 protein to inhibit EMT-driven colorectal cancer proliferation and metastasis, extending the TSC22D2 interactome to lipid metabolism enzymes.","evidence":"Co-IP/MS, Western blot, in vitro and in vivo subcutaneous tumor models","pmids":["38476309"],"confidence":"Medium","gaps":["Mechanism by which TSC22D2 stabilizes ACOT8 not identified","Whether ACOT8 stabilization occurs via blocking ubiquitination unknown"]},{"year":2024,"claim":"The central mechanistic breakthrough came with the demonstration that TSC22D2 physically joins WNK1 and NRBP1 in biomolecular condensates within seconds of hyperosmotic stress, dependent on intrinsically disordered regions — unifying the earlier NRBP1 and osmosensing findings into a condensate-based signaling model.","evidence":"Live-cell imaging, CRISPR endogenous tagging, proximity labeling, IP, evolutionary co-occurrence analysis in Cell Reports","pmids":["38980795"],"confidence":"High","gaps":["Whether TSC22D2 itself has IDR-driven phase separation capacity or is recruited passively was not resolved","Stoichiometry of the condensate complex unknown"]},{"year":2025,"claim":"Two companion studies resolved the adaptor function: TSC22D proteins bridge NRBP1 to WNK kinases via RΦ-motif–CCT domain interactions, NRBP1 directly activates WNK4 in vitro, and long TSC22D isoforms including TSC22D2 positively modulate WNK4-dependent NCC phosphorylation in the kidney distal convoluted tubule — establishing a complete osmosensing–ion transport axis.","evidence":"Reciprocal IP/MS, in vitro kinase reconstitution (recombinant NRBP1 activating WNK4), AlphaFold-3 structural modeling, immunofluorescence in DCT, DCT-specific NRBP1 KO mice","pmids":["40668933","40668923"],"confidence":"High","gaps":["Structural validation of AlphaFold-predicted RΦ-motif–CCT interface by experimental methods (cryo-EM/crystallography) is lacking","Relative contributions of TSC22D2 vs other TSC22D family members in the kidney not genetically separated","Whether the condensate-based WNK activation mechanism operates in non-renal tissues is untested"]},{"year":null,"claim":"Key open questions include whether TSC22D2 has intrinsic enzymatic or transcriptional activity beyond its adaptor role, how its tumor-suppressive functions (PKM2 sequestration, ACOT8 stabilization) relate mechanistically to its condensate biology, and whether TSC22D2-specific knockout phenotypes differ from other TSC22D family members in vivo.","evidence":"","pmids":[],"confidence":"Low","gaps":["No TSC22D2-specific conditional knockout mouse phenotype reported","No crystal or cryo-EM structure of TSC22D2 or its complexes","Relationship between cancer-suppressive and osmosensing functions unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[7,8,9]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[7,9]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7,9]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,8,9]}],"complexes":["WNK1-NRBP1-TSC22D condensate complex"],"partners":["WNK1","NRBP1","WNK4","PKM2","ACOT8","SPAK"],"other_free_text":[]},"mechanistic_narrative":"TSC22D2 functions as a molecular adaptor that bridges NRBP1 pseudokinase and WNK kinases within biomolecular condensates to transduce osmotic stress signals into cell volume regulation and renal ion transport. Upon hyperosmotic stress, TSC22D2 rapidly associates with WNK1 and NRBP1 into cytoplasmic condensates (WNK bodies) via intrinsically disordered regions; within these condensates, TSC22D2 positively modulates WNK4 kinase activity, driving NCC phosphorylation and Na+ reabsorption in the distal convoluted tubule of the kidney [PMID:38980795, PMID:40668933, PMID:40668923]. TSC22D2 is also stabilized post-transcriptionally under osmotic stress to promote cell survival [PMID:17147695], and independently suppresses colorectal cancer cell growth by sequestering PKM2 from the nucleus and stabilizing ACOT8 to inhibit epithelial-mesenchymal transition [PMID:27573352, PMID:38476309]. TSC22D2 protein levels are regulated by NRBP1-dependent ubiquitination in intestinal progenitor cells, and TSC22D2 participates in STAT3 and AMPKα-mTOR signaling in macrophages to modulate inflammatory responses [PMID:22510880, PMID:37554446]."},"prefetch_data":{"uniprot":{"accession":"O75157","full_name":"TSC22 domain family protein 2","aliases":["TSC22-related-inducible leucine zipper protein 4"],"length_aa":780,"mass_kda":79.2,"function":"Reduces the level of nuclear PKM isoform M2 which results in repression of cyclin CCND1 transcription and reduced cell growth","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/O75157/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TSC22D2","classification":"Not Classified","n_dependent_lines":501,"n_total_lines":1208,"dependency_fraction":0.4147350993377483},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"NRBP1","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/search/TSC22D2","total_profiled":1310},"omim":[{"mim_id":"617724","title":"TSC22 DOMAIN FAMILY, MEMBER 2; TSC22D2","url":"https://www.omim.org/entry/617724"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TSC22D2"},"hgnc":{"alias_symbol":["KIAA0669","TILZ4a","TILZ4b","TILZ4c"],"prev_symbol":[]},"alphafold":{"accession":"O75157","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75157","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75157-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75157-F1-predicted_aligned_error_v6.png","plddt_mean":47.03},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TSC22D2","jax_strain_url":"https://www.jax.org/strain/search?query=TSC22D2"},"sequence":{"accession":"O75157","fasta_url":"https://rest.uniprot.org/uniprotkb/O75157.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75157/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75157"}},"corpus_meta":[{"pmid":"17147695","id":"PMC_17147695","title":"Specific TSC22 domain transcripts are hypertonically induced and alternatively spliced to protect mouse kidney cells during osmotic stress.","date":"2006","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/17147695","citation_count":52,"is_preprint":false},{"pmid":"22510880","id":"PMC_22510880","title":"Nuclear receptor binding protein 1 regulates intestinal progenitor cell homeostasis and tumour formation.","date":"2012","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22510880","citation_count":46,"is_preprint":false},{"pmid":"27573352","id":"PMC_27573352","title":"TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer.","date":"2016","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27573352","citation_count":42,"is_preprint":false},{"pmid":"27337956","id":"PMC_27337956","title":"Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27337956","citation_count":36,"is_preprint":false},{"pmid":"31125406","id":"PMC_31125406","title":"TSC22D2 identified as a candidate susceptibility gene of multi-cancer pedigree using genome-wide linkage analysis and whole-exome sequencing.","date":"2019","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31125406","citation_count":29,"is_preprint":false},{"pmid":"30053002","id":"PMC_30053002","title":"Multitrait meta-analysis identified genomic regions associated with sexual precocity in tropical beef cattle.","date":"2018","source":"Journal of animal science","url":"https://pubmed.ncbi.nlm.nih.gov/30053002","citation_count":29,"is_preprint":false},{"pmid":"38980795","id":"PMC_38980795","title":"The TSC22D, WNK, and NRBP gene families exhibit functional buffering and evolved with Metazoa for cell volume regulation.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/38980795","citation_count":14,"is_preprint":false},{"pmid":"36894917","id":"PMC_36894917","title":"A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma.","date":"2023","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36894917","citation_count":13,"is_preprint":false},{"pmid":"37833839","id":"PMC_37833839","title":"MSI-XGNN: an explainable GNN computational framework integrating transcription- and methylation-level biomarkers for microsatellite instability detection.","date":"2023","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/37833839","citation_count":10,"is_preprint":false},{"pmid":"38476309","id":"PMC_38476309","title":"TSC22D2 Regulates ACOT8 to Delay the Malignant Progression of Colorectal Cancer.","date":"2024","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/38476309","citation_count":6,"is_preprint":false},{"pmid":"37070032","id":"PMC_37070032","title":"Deciphering molecular mechanisms of SARS-CoV-2 pathogenesis and drug repurposing through GRN motifs: a comprehensive systems biology study.","date":"2023","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/37070032","citation_count":6,"is_preprint":false},{"pmid":"37554446","id":"PMC_37554446","title":"Roquin-1 resolves sepsis-associated acute liver injury by regulating inflammatory profiles via miRNA cargo in extracellular vesicles.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37554446","citation_count":6,"is_preprint":false},{"pmid":"35100036","id":"PMC_35100036","title":"Specific Regulatory Motifs Network in SARS-CoV-2-Infected Caco-2 Cell Line, as a Model of Gastrointestinal Infections.","date":"2022","source":"Cellular reprogramming","url":"https://pubmed.ncbi.nlm.nih.gov/35100036","citation_count":6,"is_preprint":false},{"pmid":"40668933","id":"PMC_40668933","title":"NRBP1 pseudokinase binds to and activates the WNK pathway in response to osmotic stress.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/40668933","citation_count":3,"is_preprint":false},{"pmid":"40668923","id":"PMC_40668923","title":"NRBP1 and TSC22D proteins affect distal convoluted tubule physiology through modulation of the WNK pathway.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/40668923","citation_count":2,"is_preprint":false},{"pmid":"39427309","id":"PMC_39427309","title":"Protocol for CRISPR-based endogenous protein tagging in mammalian cells.","date":"2024","source":"STAR protocols","url":"https://pubmed.ncbi.nlm.nih.gov/39427309","citation_count":1,"is_preprint":false},{"pmid":"39764004","id":"PMC_39764004","title":"NRBP1 and TSC22D proteins impact distal convoluted tubule physiology through modulation of the WNK pathway.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39764004","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10293,"output_tokens":2457,"usd":0.033867},"stage2":{"model":"claude-opus-4-6","input_tokens":5779,"output_tokens":2257,"usd":0.12798},"total_usd":0.161847,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"TSC22D2 transcripts are transiently upregulated by hyperosmolality in mouse kidney cells (mIMCD3) via mRNA stabilization, and overexpression of TSC22D2-4 confers protection against osmotic stress, increasing cell survival 2.7-fold at high osmolality.\",\n      \"method\": \"mRNA stability assays, overexpression in mIMCD3 cells with osmotic stress survival assay\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean overexpression with defined phenotypic readout and mechanistic basis (mRNA stabilization), single lab\",\n      \"pmids\": [\"17147695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TSC22D2 protein accumulates upon loss of NRBP1 in the intestine, placing TSC22D2 downstream of NRBP1-mediated ubiquitination machinery in intestinal progenitor cell fate regulation.\",\n      \"method\": \"Genetic loss-of-function (Nrbp1 somatic deletion in mouse intestine), immunoblotting for Tsc22d2 accumulation, interaction studies with ubiquitination machinery\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with defined cellular phenotype and pathway placement, single lab\",\n      \"pmids\": [\"22510880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TSC22D2 directly interacts with pyruvate kinase isoform M2 (PKM2); overexpression of TSC22D2 reduces nuclear PKM2 levels and suppresses cyclin D1 expression, inhibiting colorectal cancer cell growth.\",\n      \"method\": \"Co-immunoprecipitation combined with mass spectrometry, immunoprecipitation, immunofluorescence, overexpression assays\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP/MS with functional follow-up, single lab, moderate orthogonal evidence\",\n      \"pmids\": [\"27573352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TSC22D2 interacts with WDR77 (a protein involved in cell cycle and tumor development), as validated by immunoprecipitation and immunofluorescence; yeast two-hybrid screening identified 44 potential TSC22D2-interacting partners involved in transcription, metabolism, and cell cycle regulation.\",\n      \"method\": \"Yeast two-hybrid screening, immunoprecipitation, immunofluorescence\",\n      \"journal\": \"Tumour biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP/pulldown with limited functional follow-up, single lab\",\n      \"pmids\": [\"27337956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The histone H4 transcription factor HINFP binds to the promoter region of TSC22D2 and may regulate its transcription.\",\n      \"method\": \"Promoter binding assay (HINFP binding to TSC22D2 promoter region), whole-exome sequencing and linkage analysis\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single binding assay without functional mutagenesis validation, single lab\",\n      \"pmids\": [\"31125406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TSC22D2 participates in STAT3 signaling and AMPKα-mTOR pathway: anti-inflammatory miRNAs in macrophage-derived extracellular vesicles decrease TSC22D2 expression, which upregulates Treg differentiation via TSC22D2-STAT3 signaling and inhibits M1 macrophage polarization via TSC22D2-AMPKα-mTOR pathway.\",\n      \"method\": \"miRNA delivery via extracellular vesicles, knockdown/pathway inhibition experiments in macrophages, in vivo mouse model of sepsis-associated acute liver injury\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with defined pathway readouts (STAT3, AMPKα-mTOR) and in vivo validation, single lab\",\n      \"pmids\": [\"37554446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TSC22D2 interacts with ACOT8 (acyl-coenzyme A thioesterase 8) and maintains ACOT8 stability; overexpression of TSC22D2 promotes ACOT8 expression and inhibits colorectal cancer cell proliferation and metastasis through an EMT mechanism.\",\n      \"method\": \"Co-immunoprecipitation combined with mass spectrometry, Western blot, immunoprecipitation, in vitro and in vivo (subcutaneous mouse model) functional assays\",\n      \"journal\": \"OncoTargets and therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP/MS with in vivo functional validation, single lab\",\n      \"pmids\": [\"38476309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Within seconds of hyperosmotic stress, TSC22D2 physically associates with WNK1 and NRBP1 into biomolecular condensates in a process dependent on intrinsically disordered regions (IDRs). TSC22D family genes co-evolved with a specific NRBP-binding domain (NbrT) in NRBPs and with IDR expansion in WNK kinases across metazoans to co-regulate rapid cell volume changes.\",\n      \"method\": \"Gene co-essentiality analysis, live-cell imaging of condensate formation, CRISPR-based endogenous protein tagging, proximity labeling, immunoprecipitation, evolutionary/domain analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (co-essentiality, imaging, proximity labeling, IP, evolutionary analysis), strong evidence for condensate formation mechanism\",\n      \"pmids\": [\"38980795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TSC22D2 physically associates with WNK1 and NRBP1 upon osmotic stress (confirmed by immunoprecipitation, mass spectrometry, and proximity labeling). NRBP1 directly activates WNK4 in vitro, and AlphaFold-3 modeling predicts TSC22D4 RΦ-motifs interact with the CCT domain of NRBP1 in a complex also containing WNK1 and SPAK; TSC22D proteins serve as adaptors bridging NRBP1 and WNK kinases in the osmosensing pathway.\",\n      \"method\": \"Proximity labeling, immunoprecipitation, mass spectrometry, immunoblotting, in vitro kinase assay (recombinant NRBP1 activating WNK4), AlphaFold-3 structural modeling, NRBP1 knockdown/knockout\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution of WNK4 activation, structural modeling, reciprocal IP/MS, KO functional validation, multiple orthogonal methods in single study\",\n      \"pmids\": [\"40668933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TSC22D2 localizes to cytoplasmic biomolecular condensates (WNK bodies) in the distal convoluted tubule (DCT) of the kidney, and long TSC22D isoforms including TSC22D2 positively modulate WNK4 activity in HEK293 cells, thereby regulating NCC phosphorylation and Na+ reabsorption in the kidney.\",\n      \"method\": \"Immunofluorescence localization in DCT, HEK293 cell overexpression with WNK4 activity assay, DCT-specific NRBP1 knockout mice with NCC phosphorylation readout\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional consequence, in vitro kinase assay, in vivo KO mouse, multiple orthogonal methods\",\n      \"pmids\": [\"40668923\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TSC22D2 is an adaptor protein that, upon hyperosmotic stress, rapidly associates with WNK1 kinase and the NRBP1 pseudokinase into biomolecular condensates via intrinsically disordered regions, where it positively modulates WNK kinase activity to regulate cell volume homeostasis, ion transport (NCC phosphorylation), and Na+ reabsorption in the kidney; additionally, TSC22D2 interacts with PKM2 and ACOT8 to suppress cancer cell growth, and its expression is regulated by HINFP at the promoter level and post-transcriptionally by mRNA stabilization during osmotic stress.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TSC22D2 functions as a molecular adaptor that bridges NRBP1 pseudokinase and WNK kinases within biomolecular condensates to transduce osmotic stress signals into cell volume regulation and renal ion transport. Upon hyperosmotic stress, TSC22D2 rapidly associates with WNK1 and NRBP1 into cytoplasmic condensates (WNK bodies) via intrinsically disordered regions; within these condensates, TSC22D2 positively modulates WNK4 kinase activity, driving NCC phosphorylation and Na+ reabsorption in the distal convoluted tubule of the kidney [PMID:38980795, PMID:40668933, PMID:40668923]. TSC22D2 is also stabilized post-transcriptionally under osmotic stress to promote cell survival [PMID:17147695], and independently suppresses colorectal cancer cell growth by sequestering PKM2 from the nucleus and stabilizing ACOT8 to inhibit epithelial-mesenchymal transition [PMID:27573352, PMID:38476309]. TSC22D2 protein levels are regulated by NRBP1-dependent ubiquitination in intestinal progenitor cells, and TSC22D2 participates in STAT3 and AMPKα-mTOR signaling in macrophages to modulate inflammatory responses [PMID:22510880, PMID:37554446].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"TSC22D2 was first linked to osmotic stress responses when its mRNA was found to be stabilized under hyperosmolality, and overexpression conferred cytoprotection — establishing TSC22D2 as an osmotically responsive gene with a pro-survival role.\",\n      \"evidence\": \"mRNA stability assays and overexpression survival assays in mIMCD3 kidney cells\",\n      \"pmids\": [\"17147695\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream mechanism of cytoprotection unknown\", \"No interacting partners identified\", \"Single cell line tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The discovery that TSC22D2 protein accumulates upon NRBP1 loss in mouse intestine established that TSC22D2 is a regulated substrate of NRBP1-dependent ubiquitination, revealing post-translational control of TSC22D2 levels.\",\n      \"evidence\": \"Somatic deletion of Nrbp1 in mouse intestine with immunoblotting for Tsc22d2\",\n      \"pmids\": [\"22510880\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether NRBP1-TSC22D2 interaction is direct or mediated by an E3 ligase was unclear\", \"Functional consequence of TSC22D2 accumulation in intestinal cells not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identification of PKM2 as a direct TSC22D2 interactor, with TSC22D2 reducing nuclear PKM2 and cyclin D1, provided the first evidence for a tumor-suppressive mechanism involving sequestration of an oncogenic metabolic enzyme.\",\n      \"evidence\": \"Co-IP/MS, immunofluorescence, and overexpression in colorectal cancer cells\",\n      \"pmids\": [\"27573352\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No loss-of-function validation of the PKM2-sequestration model\", \"Mechanism of PKM2 nuclear exclusion not defined\", \"In vivo tumor suppression not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"TSC22D2 was placed in immune signaling when knockdown showed it modulates Treg differentiation via STAT3 and M1 macrophage polarization via AMPKα-mTOR, broadening its known functions beyond osmotic stress and cancer.\",\n      \"evidence\": \"miRNA-mediated knockdown in macrophages with pathway inhibition, in vivo sepsis mouse model\",\n      \"pmids\": [\"37554446\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether TSC22D2 acts as a direct signaling node or a transcriptional target in these pathways is unclear\", \"Single disease model (sepsis-associated liver injury)\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"A second tumor-suppressive mechanism was identified: TSC22D2 stabilizes ACOT8 protein to inhibit EMT-driven colorectal cancer proliferation and metastasis, extending the TSC22D2 interactome to lipid metabolism enzymes.\",\n      \"evidence\": \"Co-IP/MS, Western blot, in vitro and in vivo subcutaneous tumor models\",\n      \"pmids\": [\"38476309\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which TSC22D2 stabilizes ACOT8 not identified\", \"Whether ACOT8 stabilization occurs via blocking ubiquitination unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"The central mechanistic breakthrough came with the demonstration that TSC22D2 physically joins WNK1 and NRBP1 in biomolecular condensates within seconds of hyperosmotic stress, dependent on intrinsically disordered regions — unifying the earlier NRBP1 and osmosensing findings into a condensate-based signaling model.\",\n      \"evidence\": \"Live-cell imaging, CRISPR endogenous tagging, proximity labeling, IP, evolutionary co-occurrence analysis in Cell Reports\",\n      \"pmids\": [\"38980795\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TSC22D2 itself has IDR-driven phase separation capacity or is recruited passively was not resolved\", \"Stoichiometry of the condensate complex unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Two companion studies resolved the adaptor function: TSC22D proteins bridge NRBP1 to WNK kinases via RΦ-motif–CCT domain interactions, NRBP1 directly activates WNK4 in vitro, and long TSC22D isoforms including TSC22D2 positively modulate WNK4-dependent NCC phosphorylation in the kidney distal convoluted tubule — establishing a complete osmosensing–ion transport axis.\",\n      \"evidence\": \"Reciprocal IP/MS, in vitro kinase reconstitution (recombinant NRBP1 activating WNK4), AlphaFold-3 structural modeling, immunofluorescence in DCT, DCT-specific NRBP1 KO mice\",\n      \"pmids\": [\"40668933\", \"40668923\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural validation of AlphaFold-predicted RΦ-motif–CCT interface by experimental methods (cryo-EM/crystallography) is lacking\", \"Relative contributions of TSC22D2 vs other TSC22D family members in the kidney not genetically separated\", \"Whether the condensate-based WNK activation mechanism operates in non-renal tissues is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include whether TSC22D2 has intrinsic enzymatic or transcriptional activity beyond its adaptor role, how its tumor-suppressive functions (PKM2 sequestration, ACOT8 stabilization) relate mechanistically to its condensate biology, and whether TSC22D2-specific knockout phenotypes differ from other TSC22D family members in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No TSC22D2-specific conditional knockout mouse phenotype reported\", \"No crystal or cryo-EM structure of TSC22D2 or its complexes\", \"Relationship between cancer-suppressive and osmosensing functions unexplored\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [7, 8, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [7, 9]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0382551\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 8, 9]}\n    ],\n    \"complexes\": [\n      \"WNK1-NRBP1-TSC22D condensate complex\"\n    ],\n    \"partners\": [\n      \"WNK1\",\n      \"NRBP1\",\n      \"WNK4\",\n      \"PKM2\",\n      \"ACOT8\",\n      \"SPAK\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}